SCHEMBL704358

SCHEMBL704358

[2H]C([2H])([2H])C(=O)OC(=O)C([2H])([2H])[2H]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1331756 1.00
SCHEMBL1330476 1.00
SCHEMBL1331778 1.00
SCHEMBL12210099 0.93
Ethaneperoxoic Acid SCHEMBL31411245 0.74
SCHEMBL23829869 0.72
Acetic Acid Methyl Ester SCHEMBL625640 0.72
SCHEMBL523 0.70
SCHEMBL9866292 0.70
SCHEMBL1331774 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230373913-A1 Methods of Making Deuterium-Enriched N-Acetylcysteine Amide (D-NACA) and (2R,2R)-3,3-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress NACUITY PHARMACEUTICALS, INC. 2023-11-23 US claimed
US-7635573-B2 Mass spectroscopic method for comparing protein levels in two or more samples AGILENT TECHNOLOGIES, INC. (US) 2009-12-22 US claimed
EP-1437596-B1 N- or C-terminal peptide selection method for proteomics AGILENT TECHNOLOGIES INC (US) 2008-04-09 EP claimed
EP-1543074-B1 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP CO LTD (KR) 2008-02-27 EP claimed
US-20060134723-A1 N-or C-terminal peptide selection method for proteomics FISCHER STEVEN M 2006-06-22 US claimed
US-7046904-B2 UV-curable resin composition for cladding optical fiber SSCP CO., LTD. (KR) 2006-05-16 US claimed
US-20060067638-A1 Uv-curable resin composition for cladding optical fiber LUVANTIX CO., LTD. (KR) 2006-03-30 US claimed
EP-1543074-A4 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP CO LTD (KR) 2006-01-04 EP claimed
EP-1543074-A1 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP Co., Ltd. (KR) 2005-06-22 EP claimed
US-20040137552-A1 N- or C-terminal peptide selection method for proteomics AGILENT TECHNOLOGIES, INC. 2004-07-15 US claimed
EP-1437596-A1 N- or C-terminal peptide selection method for proteomics Agilent Technologies, Inc. (US) 2004-07-14 EP claimed
WO-2004024814-A1 UV-CURABLE RESIN COMPOSITION FOR CLADDING OPTICAL FIBER SSCP CO., LTD. (KR) 2004-03-25 WO claimed
WO-2025048639-A1 CHITOSAN AND ORGANIC ACID HAVING A PKA OF 4 OR MORE, OR A SALT THEREOF IN BAKERY PRODUCTS MAURI TECHNOLOGY B.V. (NL) 2025-03-06 WO disclosed
US-20240217927-A1 Methods of Making Deuterium-Enriched N-Acetylcysteine Amide (D-NACA) and (2R,2R)-3,3-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress NACUITY PHARMACEUTICALS, INC. 2024-07-04 US disclosed
CN-117279914-A SOS1 inhibitor and preparation method and application thereof 南京再明医药有限公司 2023-12-22 CN disclosed
CN-110278711-B Tricyclosulfones as rory modulators 百时美施贵宝公司 2023-12-15 CN disclosed
EP-1051655-A1 METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY Ista Pharmaceuticals, Inc. (US) 2000-11-15 EP disclosed
EP-0610063-B1 Regioselective enzymatic deacylation of sucrose esters in anhydrous organic media MCNEIL PPC INC (US) 2000-05-03 EP disclosed
WO-1999039238-A1 METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY KERATOFORM, INC. (US) 1999-08-05 WO disclosed
EP-0610063-A2 Regioselective enzymatic deacylation of sucrose esters in anhydrous organic media McNEIL-PPC, INC. (US) 1994-08-10 EP disclosed